Parkinson's disease decisions — 2023

The Board granted service connection for prostate cancer as secondary to service-connected prostatitis, but denied claims for Parkinson's disease and diabetes mellitus type II based on herbicide agent exposure and/or radiation exposure. The claim for hernia and its residuals was remanded.

The Board dismissed the appeal as there is no longer a case or controversy to resolve regarding service connection for Parkinson's disease.

The Board denied service connection for hypothyroidism and Parkinsonism, finding no evidence of exposure to herbicide agents during service and insufficient evidence linking the conditions to service.

The Board has determined that the Veteran requires personal care services due to his Parkinson's disease, which necessitates supervision and protection. The PCAFC benefits are granted.

The Board has remanded the case due to insufficient evidence regarding the Veteran's in-service exposure to herbicide agents and the presence of a current neurological disorder, specifically Parkinson's Disease and restless leg syndrome. The Veteran is requested to provide additional information or evidence to support his claims.

The Board has determined that there are insufficient records to make a determination on the service connection claims for various disabilities. The Veteran's exposure history and prior service need further clarification, as well as additional medical opinions regarding peripheral artery disease and neuropathy.

The Board has determined that new and relevant evidence has been submitted to warrant readjudication of the Veteran's claims for service connection for Parkinson's disease, peripheral neuropathy of the legs, loss of bladder control, and dizziness. The case is REMANDED for further examination and opinion.

The Veteran's claims for increased ratings and effective dates have been dismissed due to his death. No service connection was established or denied.

The Board has dismissed the appeals for service connection for various conditions as they are related to a deceased appellant.

The Board denied the Veteran's claims of service connection for Parkinson's disease, sleep apnea, diabetes mellitus, and erectile dysfunction. The evidence did not show a nexus to service.

The Board has granted service connection for Parkinson's disease and a psychiatric disorder, including chronic PTSD, depression, and anxiety. The Veteran's current conditions are related to his active service.

The Veteran's claim for a higher rating for his service-connected PTSD and Parkinson's disease was denied by the Board. The criteria for a disability rating in excess of 70 percent were not met, as the symptoms did not cause total occupational and social impairment.

The Board has found that there has not been substantial compliance with the prior November 2022 remand and further development is necessary for both Parkinson's disease and psychiatric disability claims.

The Board denied service connection for Parkinson's disease, including as due to Agent Orange exposure, finding insufficient evidence of herbicide exposure and no causal link between the condition and service.

The Board has reopened the Veteran's claim for service connection for Wolff-Parkinson-White syndrome due to new and material evidence. However, the case is remanded as there are issues regarding whether the condition pre-existed service or was aggravated by service.

The Board has granted service connection for diabetes mellitus, type II and Parkinson's disease, both of which are presumed to be due to in-service exposure to herbicide agents. The decision is based on the Veteran's presence at a Thai military base during his active duty service.

The Board has remanded the Veteran's claims for service connection for Traumatic Brain Injury residuals, Parkinson's disease, and right ear hearing loss due to new evidence received after the last final rating decision. The TDIU claim is also remanded as it is intertwined with these other claims.

The Veteran's Parkinson's disease is denied as there was no service connection due to lack of exposure at Camp LeJeune and insufficient evidence linking the condition to his active duty.

The Veteran's TDIU claim due to service-connected Parkinson's disease residuals from February 27, 2020 is dismissed as the maximum benefit has already been granted.

The Board denied the Veteran's claim for service connection for Parkinson's Disease due to herbicide agent exposure along the Korean DMZ, finding that there was no evidence of exposure and that the current disability did not arise from active service.